Friday, December 18, 2015

FDA proposes youth sunlamp restrictions

The U.S. Food and Drug Administration announced important proposed steps ‎to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults. The FDA is committed to protecting public health by informing consumers of the risks of indoor tanning.

Indoor tanning is a known contributor to skin cancer, including melanoma (its most deadly form), and other skin damage. Yet, 1.6 million minors indoor tan each year, increasing their risk of skin cancer and other damage (based on data in the 2013 National Youth Risk Behavior Survey).

According to the American Academy of Dermatology, those who have been exposed to radiation from indoor tanning are 59 percent more likely to develop melanoma than those who have never tanned indoors.

In addition, the effects of exposure to UV radiation add up over one’s lifetime. Therefore, UV radiation exposure in children and teenagers puts them at a greater risk for skin and eye damage later in life.

The FDA is issuing two proposed rules today. The first proposed rule would restrict use of sunlamp products to individuals 18 and older. The second proposed rule would require that sunlamp manufacturers and tanning facilities take additional measures to improve the overall safety of these devices.

The proposed rules are available online at www.regulations.gov for public comment for 90 days.

How to Comment on the Proposed Rules

To comment on the Restricted Sale, Distribution, and Use of Sunlamp Products:
Read the proposed rule.
Starting Monday, December 21, submit comments on the proposed rule on Regulations.gov.

To comment on the Amendment to the Performance Standard for Sunlamp Products:
Read the proposed rule.
Starting Monday, December 21, submit comments on the proposed rule on Regulations.gov.

The rules will be available for public comment for 90 days.

No comments:

Post a Comment